123 related articles for article (PubMed ID: 28650667)
21.
Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
[TBL] [Abstract][Full Text] [Related]
22. The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet.
Lutz SZ; Hennige AM; Peter A; Kovarova M; Totsikas C; Machann J; Kröber SM; Sperl B; Schleicher E; Schick F; Heni M; Ullrich A; Häring HU; Stefan N
J Clin Endocrinol Metab; 2019 Jun; 104(6):2041-2053. PubMed ID: 30541128
[TBL] [Abstract][Full Text] [Related]
23. FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
Spinola M; Leoni VP; Tanuma J; Pettinicchio A; Frattini M; Signoroni S; Agresti R; Giovanazzi R; Pilotti S; Bertario L; Ravagnani F; Dragani TA
Oncol Rep; 2005 Aug; 14(2):415-9. PubMed ID: 16012724
[TBL] [Abstract][Full Text] [Related]
24. Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?
Katarzyna S
J Cancer Res Ther; 2023; 19(2):355-358. PubMed ID: 37006072
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
Chen Q; Li WJ; Wan YY; Yu CD; Li WG
Genet Mol Res; 2012 Mar; 11(1):548-55. PubMed ID: 22535390
[TBL] [Abstract][Full Text] [Related]
26. Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients.
Spinola M; Leoni V; Pignatiello C; Conti B; Ravagnani F; Pastorino U; Dragani TA
J Clin Oncol; 2005 Oct; 23(29):7307-11. PubMed ID: 16061909
[TBL] [Abstract][Full Text] [Related]
27. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
28. FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
Ho CK; Anwar S; Nanda J; Habib FK
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):94-6. PubMed ID: 19918264
[TBL] [Abstract][Full Text] [Related]
29. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas.
Wimmer E; Ihrler S; Gires O; Streit S; Issing W; Bergmann C
World J Clin Oncol; 2019 Mar; 10(3):136-148. PubMed ID: 30949443
[TBL] [Abstract][Full Text] [Related]
31. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
32. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
[TBL] [Abstract][Full Text] [Related]
33. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
[TBL] [Abstract][Full Text] [Related]
34. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Matakidou A; El Galta R; Rudd MF; Webb EL; Bridle H; Eisen T; Houlston RS
Br J Cancer; 2007 Jun; 96(12):1904-7. PubMed ID: 17519899
[TBL] [Abstract][Full Text] [Related]
35. FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.
Dutra RL; de Carvalho MB; Dos Santos M; Mercante AM; Gazito D; de Cicco R; Group G; Tajara EH; Louro ID; da Silva AM
PLoS One; 2012; 7(11):e50747. PubMed ID: 23226373
[TBL] [Abstract][Full Text] [Related]
36. Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.
Yang YC; Lu ML; Rao JY; Wallerand H; Cai L; Cao W; Pantuck A; Dalbagni G; Reuter V; Figlin RA; Belldegrun A; Cordon-Cardo C; Zhang ZF
Br J Cancer; 2006 Dec; 95(11):1455-8. PubMed ID: 17088904
[TBL] [Abstract][Full Text] [Related]
37. Association of the Collagen Type IV Alpha 1 Chain Gene rs3783107 GG Genotype with Hypertension, Asthma, and Eczema: The Tampere Adult Population Cardiovascular Risk Study.
Kunnas T; Nikkari ST
Genet Test Mol Biomarkers; 2020 Jan; 24(1):6-9. PubMed ID: 31815553
[No Abstract] [Full Text] [Related]
38. Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.
Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
[TBL] [Abstract][Full Text] [Related]
39. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
[TBL] [Abstract][Full Text] [Related]
40. Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.
Gouni-Berthold I; Giannakidou E; Faust M; Kratzsch J; Berthold HK; Krone W
J Intern Med; 2005 Dec; 258(6):518-26. PubMed ID: 16313475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]